Paul Herendeen Biography and Net Worth

Director of Elanco Animal Health

Paul Herendeen has served as a member of the Elanco Board of Directors since December 2020.

Herendeen served as Advisor to the Chairman and Chief Executive Officer at Bausch Health Companies Inc. Prior to that, he was Executive Vice President (EVP) and Chief Financial Officer (CFO) of Bausch Health. Before joining Bausch Health, he served as EVP and CFO of Zoetis Inc. Prior to that time, Herendeen served as chief financial officer at Warner Chilcott, a specialty pharmaceuticals company. He rejoined Warner Chilcott after four years as EVP and CFO of MedPointe. Herendeen previously worked as a Principal Investor at Dominion Income Management and Cornerstone Partners, and spent the early part of his career in banking and public accounting, holding various positions with the investment banking group of Oppenheimer & Company, the capital markets group of Continental Bank Corporation and as a Senior Auditor with Arthur Andersen & Company.

Herendeen holds a bachelor's degree from Boston College and earned a MBA from the University of Virginia's Darden School of Business.

What is Paul Herendeen's net worth?: The estimated net worth of Paul Herendeen is at least $2.49 million as of August 7th, 2026. Mr. Herendeen owns 111,687 shares of Elanco Animal Health stock worth more than $2,486,599 as of September 25th. This net worth evaluation does not reflect any other investments that Mr. Herendeen may own. Learn More about Paul Herendeen's net worth.
How do I contact Paul Herendeen?: The corporate mailing address for Mr. Herendeen and other Elanco Animal Health executives is 450 Elanco Circle, Indianapolis, IN, 46221. Elanco Animal Health can also be reached via phone at (877) 352-6261 and via email at [email protected]. Learn More on Paul Herendeen's contact information.
Has Paul Herendeen been buying or selling shares of Elanco Animal Health?: During the past quarter, Paul Herendeen has bought $236,800.00 of Elanco Animal Health stock. Most recently, on Friday, August 7th, Paul Herendeen bought 10,000 shares of Elanco Animal Health stock. The stock was acquired at an average cost of $23.68 per share, with a total value of $236,800.00. Following the completion of the transaction, the director now directly owns 111,687 shares of the company's stock, valued at $2,644,748.16. Learn More on Paul Herendeen's trading history.
Who are Elanco Animal Health's active insiders?: Elanco Animal Health's insider roster includes John Bilbrey (Director), Art Garcia (Director), Michael Harrington (Director), Paul Herendeen (Director), R. Hoover (Director), Lawrence Kurzius (Director), Rajeev Modi (Insider), Shiv O'Neill (Executive Vice President, General Counsel and Corporate Secretary), Jeffrey Simmons (President & CEO), Robert Vanhimbergen (CFO), and Todd Young (Insider). Learn More on Elanco Animal Health's active insiders.
Are insiders buying or selling shares of Elanco Animal Health?: During the last year, Elanco Animal Health insiders bought shares 11 times. They purchased a total of 116,530 shares worth more than $2,610,798.08. The most recent insider tranaction occured on August, 20th when Director Lawrence Erik Kurzius bought 40,000 shares worth more than $936,000.00. Insiders at Elanco Animal Health own 1.1% of the company. Learn More about insider trades at Elanco Animal Health.
Information on this page was last updated on 8/20/2026.

Paul Herendeen Insider Trading History at Elanco Animal Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/7/2026	Buy	10,000	$23.68	$236,800.00	111,687

Paul Herendeen Buying and Selling Activity at Elanco Animal Health

Elanco Animal Health Company Overview

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Today's Range

Now: $22.47

$22.10

$22.51

50 Day Range

MA: $24.11

$22.06

$26.48

2 Week Range

Now: $22.47

$18.93

$27.98

Volume

1,663,032 shs

Average Volume

5,643,594 shs

Market Capitalization

$11.22 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.68